GENN Stock Overview
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
Genesis Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0011 |
| 52 Week High | US$0.38 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -83.33% |
| 3 Year Change | -99.58% |
| 5 Year Change | -99.91% |
| Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
| GENN | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -0.7% |
| 1Y | -83.3% | 1.3% | 22.3% |
Return vs Industry: GENN underperformed the US Healthcare industry which returned 0.7% over the past year.
Return vs Market: GENN underperformed the US Market which returned 22.8% over the past year.
Price Volatility
| GENN volatility | |
|---|---|
| GENN Average Weekly Movement | 238.8% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: GENN's share price has been volatile over the past 3 months.
Volatility Over Time: GENN's weekly volatility has decreased from 26524% to 239% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | n/a | n/a |
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.
Genesis Healthcare, Inc. Fundamentals Summary
| GENN fundamental statistics | |
|---|---|
| Market cap | US$194.44k |
| Earnings (TTM) | -US$58.96m |
| Revenue (TTM) | US$3.91b |
0.0x
P/S Ratio0.0x
P/E RatioIs GENN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GENN income statement (TTM) | |
|---|---|
| Revenue | US$3.91b |
| Cost of Revenue | US$2.26b |
| Gross Profit | US$1.65b |
| Other Expenses | US$1.71b |
| Earnings | -US$58.96m |
Last Reported Earnings
Dec 31, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did GENN perform over the long term?
See historical performance and comparison